Analysis of patient access to orphan drugs in Turkey

被引：0
|
作者：
Güvenç Koçkaya
Sibel Atalay
Gülpembe Oğuzhan
Mustafa Kurnaz
Selin Ökçün
Çiğdem Sar Gedik
Mete Şaylan
Nazlı Şencan
机构：
[1] Econix Research,
[2] Analysis and Consulting Inc.,undefined
[3] Gen Pharmaceuticals and Health Products Inc.,undefined
[4] Ondokuz Mayıs University,undefined
[5] Acıbadem University,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Rare disease drug; Orphan drug; Orphan drug market;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Analysis of patient access to orphan drugs in Turkey
    Kockaya, Guvenc
    Atalay, Sibel
    Oguzhan, Gulpembe
    Kurnaz, Mustafa
    Okcun, Selin
    Sar Gedik, Cigdem
    Saylan, Mete
    Sencan, Nazli
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [2] Patient access to orphan drugs
    Cohen, Joshua P.
    Awatin, Josephine G.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (12): : 923 - 932
  • [3] PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY
    Kockaya, G.
    Ergin, Oguzhan G.
    Kurnaz, M.
    Okcun, S.
    Talay, D.
    Gedik, Sar C.
    Saylan, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S854 - S855
  • [4] Patient access to orphan drugs in France
    Bourdoncle, Marion
    Juillard-Condat, Blandine
    Taboulet, Florence
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [5] Patient access to orphan drugs in France
    Marion Bourdoncle
    Blandine Juillard-Condat
    Florence Taboulet
    [J]. Orphanet Journal of Rare Diseases, 14
  • [6] Orphan drugs: pricing, reimbursement and patient access
    Barak, Adam
    Nandi, Jyoti Shankar
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2011, 5 (04) : 299 - 317
  • [7] International differences in patient access to ultra-orphan drugs
    Kanters, Tim A.
    Redekop, W. Ken
    Hakkaart, Leona
    [J]. HEALTH POLICY AND TECHNOLOGY, 2018, 7 (01) : 57 - 64
  • [8] ACCESS TO ORPHAN DRUGS IN HUNGARY
    Rozsa, P.
    Oross-Becsi, R.
    Toth, G.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S239 - S239
  • [9] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
    Ounsirithupsakul, T.
    Samphansompoch, T.
    Sermsakulthai, T.
    Taychakhoonavudh, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [10] MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS
    Malacan, J.
    Gabriel, S.
    Dinet, J.
    Forget, S.
    Borget, I
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
12345